Rationale and Design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) RCT# NCT02344290

BACKGROUND: Cardiovascular disease (CVD) is more frequent among people with HIV (PWH) and may relate to traditional and nontraditional factors, including inflammation and immune activation. A critical need exists to develop effective strategies to prevent CVD in this population. METHODS: The Randomi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am Heart J
Autors principals: Grinspoon, Steven K., Fitch, Kathleen V., Overton, Edgar Turner, Fichtenbaum, Carl J., Zanni, Markella V., Aberg, Judith A., Malvestutto, Carlos, Lu, Michael T., Currier, Judith S., Sponseller, Craig A., Waclawiw, Myron, Alston-Smith, Beverly, Cooper-Arnold, Katharine, Klingman, Karin L., Desvigne-Nickens, Patrice, Hoffmann, Udo, Ribaudo, Heather J., Douglas, Pamela S.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535121/
https://ncbi.nlm.nih.gov/pubmed/30928825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2018.12.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars